Stocks · Healthcare · Biotechnology
Anixa Biosciences, Inc. ANIX
$2.95 +0.00% Close, Oct 5, 2026 · NASDAQ · Market cap $100.4M
Next earnings report: Jan 11, 2027
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- Diluted EPS over the last four quarters was $-0.30, down 777.8% year over year.
- The stock is 43% below its highest close of the past year.
- The company holds net cash of $1.2M (cash above total debt).
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 6, 2026.
How fast revenue, earnings and cash flow are growing.
- EPS growth (TTM, YoY)Bottom 4%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalBottom 14%
- Accruals (lower is better)Top 14%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldBottom 45%
- Free-cash-flow yieldBottom 43%
- EBITDA / enterprise valueBottom 38%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthBottom 32%
- 6-month returnTop 45%
- 1-year return vs S&P 500Bottom 35%
- Distance from 52-week highBottom 33%
- Trend checklist (0–4)Top 43%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersTop 37%
- Consecutive EPS beatsTop 25%
- Share of analysts rating BuyTop 10%
- Upside to consensus price targetTop 36%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Bottom 48%
- Maximum drawdown, 3 yearsTop 31%
- Beta vs S&P 500 (lower is better)Top 26%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| EPS growth (YoY) | -2157.2% | -777.8% | ↑ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| EPS growth (TTM, YoY) | -777.8% | -2157.2% | ↑ | Bottom 4% |
| Return on invested capital | -82.1% | — | Bottom 14% |
Quality of earnings and balance sheet
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -20.2%
- Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
- Net cash
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.00%
- Net buyback yield (TTM)
- -2.34%
- Shareholder yield
- -2.34%
- Share count change, 1 year
- +5.3%
- Share count change, 3-year CAGR
- +3.3%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jul 31, 2026 (filed Sep 9, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 3
- Beats in the last 8 reports
- 6 of 8
- Average EPS surprise, last 4
- +10.5%
- Average 2-day reaction, last 8
- -0.3%
- Positive 20 days after report
- 4 of 7
Analysts
- Consensus price target
- $6.00
- Target vs current price
- +103.4%
- Analysts with a rating
- 6
- Share rating Buy or Strong Buy
- 100%
- Consensus rating
- Buy
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Sep 9, 2026 | +3.3% | -2.4% | -7.2% | — | — |
| Jun 10, 2026 | +30.0% | -2.1% | +8.7% | +34.2% | +27.1% |
| Mar 9, 2026 | +11.1% | +4.6% | -0.7% | -9.1% | -10.5% |
| Jan 12, 2026 | -2.3% | -6.5% | -5.6% | -11.8% | -19.2% |
| Sep 10, 2025 | +30.0% | +1.3% | +20.8% | +37.9% | +62.8% |
| May 28, 2025 | +10.0% | +1.6% | +12.8% | +32.4% | +18.0% |
| Mar 11, 2025 | +0.0% | +1.1% | +15.2% | -5.3% | +6.1% |
| Jan 10, 2025 | +18.2% | +0.0% | +14.7% | +40.4% | +10.7% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Sep 9, 2026 | -$0.08 | -$0.08 | +3.3% | — |
| Jun 10, 2026 | -$0.07 | -$0.10 | +30.0% | — |
| Mar 9, 2026 | -$0.08 | -$0.09 | +11.1% | — |
| Jan 12, 2026 | -$0.09 | -$0.09 | -2.3% | — |
| Sep 10, 2025 | -$0.07 | -$0.10 | +30.0% | — |
| May 28, 2025 | -$0.09 | -$0.10 | +10.0% | — |
| Mar 11, 2025 | -$0.10 | -$0.10 | +0.0% | — |
| Jan 10, 2025 | -$0.09 | -$0.11 | +18.2% | — |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| Free-cash-flow yield | -7.35% | — | — | Bottom 43% |
| Earnings yield | -10.34% | — | — | Bottom 45% |
Technical state
Trend checklist
- ✓ Price above 20-day average
- ✗ Price above 50-day average
- ✗ Price above 200-day average
- ✓ 50-day average above 200-day
- ✓ MACD histogram positive
Trend quality
- Days above the 50-day average
- 0
- Days above the 200-day average
- 0
- 50-day average slope (20 days)
- -5.3%
- 200-day average slope (20 days)
- -5.2%
- Distance from 50-day average
- -6.8%
- Distance from 200-day average
- -1.7%
- RSI (14)
- 50.6
- Relative volume
- 0.97×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 56.5%
- Volatility vs own 5-year history
- 19th percentile · Low for this stock
- Beta vs S&P 500 (2 years, weekly)
- 0.68
- Correlation with S&P 500
- 0.18
- Current drawdown from 1-year high
- -43.5%
- Maximum drawdown, 3 years
- -57.6%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Mar 17, 2021 | Jan 14, 2025 | -70.2% | 962 days | Not yet recovered |
| Oct 1, 2020 | Nov 9, 2020 | -34.7% | 27 days | 20 days (Dec 8, 2020) |
| Feb 16, 2021 | Mar 8, 2021 | -21.5% | 14 days | 4 days (Mar 12, 2021) |
| Jan 15, 2021 | Jan 28, 2021 | -19.1% | 8 days | 4 days (Feb 3, 2021) |
| Dec 10, 2020 | Dec 14, 2020 | -16.2% | 2 days | 11 days (Dec 30, 2020) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $100.4M
- EPS, diluted (TTM)
- -$0.31
- Revenue (TTM)
- $0
- 52-week range
- $2.32 – $5.46
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $512,000 | $0 | $210,000 | $0 | $0 |
| Gross profit | $127,000 | $0 | $49,000 | $0 | -$36,000 |
| Operating income | -$13.1M | -$13.9M | -$11.0M | -$13.8M | -$11.7M |
| Net income | -$12.9M | -$13.6M | -$9.8M | -$12.6M | -$10.9M |
| EPS (diluted) | -$0.45 | -$0.45 | -$0.32 | -$0.39 | -$0.34 |
| Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | Q3 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net income | -$2.9M | -$3.2M | -$2.8M | -$2.3M | -$2.7M | -$2.6M | -$2.6M | -$2.6M |
| EPS (diluted) | $0.30 | -$0.10 | -$0.09 | -$0.07 | -$0.08 | -$0.08 | -$0.07 | -$0.08 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | -$4.9M | -$6.5M | -$6.2M | -$7.3M | -$7.2M |
| Capital expenditure | $0 | $0 | $0 | $0 | $0 |
| Free cash flow | -$4.9M | -$6.5M | -$6.2M | -$7.3M | -$7.2M |
| Dividends paid | $0 | $0 | $0 | $0 | $0 |
| Net share buybacks | $31.1M | $0 | $0 | $2.9M | $2.3M |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $13.9M
- Total assets
- $15.1M
- Total liabilities
- $1.9M
- Total debt
- $174,000
- Net debt
- -$1.2M
- Shareholders’ equity
- $14.5M
As of Jul 31, 2026 (filed Sep 9, 2026).
Short interest
- Shares sold short
- 1,054,934
- Days to cover
- 2.72
- Change vs previous report
- +6.2%
FINRA short interest, settlement date Sep 15, 2026.
Stock splits
- Jun 26, 2015
- 1-for-25
- Jun 18, 1996
- 2-for-1
- Mar 19, 1991
- 2-for-1
- Sep 16, 1987
- 5-for-4
- Nov 12, 1985
- 3-for-1